Article info
PDFLetter
Palivizumab prophylaxis in haemodynamically significant congenital heart disease
- Correspondence to:
Dr T F Feltes
6th Floor, Education, 700 Children’s Drive, Columbus, Ohio 43205, USA; tfelteschi.osu.edu
Citation
Palivizumab prophylaxis in haemodynamically significant congenital heart disease
Publication history
- First published July 22, 2005.
Online issue publication
July 22, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Archives of Disease in Childhood